Biogen Inc Stock Net Income
| BIIB Stock | USD 158.01 2.01 1.29% |
Biogen Inc fundamentals help investors to digest information that contributes to Biogen's financial success or failures. It also enables traders to predict the movement of Biogen Stock. The fundamental analysis module provides a way to measure Biogen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biogen stock.
Biogen |
Biogen Inc Company Net Income Analysis
Biogen's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Biogen Net Income | 1.16 B |
Most of Biogen's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Biogen Inc reported net income of 1.16 B. This is 240.33% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 103.42% lower than that of the firm.
Biogen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.Biogen is currently under evaluation in net income category among its peers.
Biogen Fundamentals
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0499 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 27.6 B | ||||
| Shares Outstanding | 145.72 M | ||||
| Shares Owned By Insiders | 0.15 % | ||||
| Shares Owned By Institutions | 92.82 % | ||||
| Number Of Shares Shorted | 3.12 M | ||||
| Price To Earning | 14.83 X | ||||
| Price To Book | 1.38 X | ||||
| Price To Sales | 2.37 X | ||||
| Revenue | 9.84 B | ||||
| Gross Profit | 7.9 B | ||||
| EBITDA | 2.38 B | ||||
| Net Income | 1.16 B | ||||
| Cash And Equivalents | 4.91 B | ||||
| Cash Per Share | 34.10 X | ||||
| Total Debt | 7.34 B | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.49 X | ||||
| Book Value Per Share | 112.28 X | ||||
| Cash Flow From Operations | 1.55 B | ||||
| Short Ratio | 2.36 X | ||||
| Earnings Per Share | 11.07 X | ||||
| Price To Earnings To Growth | 6.24 X | ||||
| Target Price | 251.7 | ||||
| Number Of Employees | 7.57 K | ||||
| Beta | -0.061 | ||||
| Market Capitalization | 22.73 B | ||||
| Total Asset | 26.84 B | ||||
| Retained Earnings | 17.63 B | ||||
| Working Capital | 3.42 B | ||||
| Current Asset | 8.73 B | ||||
| Current Liabilities | 3.42 B | ||||
| Net Asset | 26.84 B |
About Biogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:Check out Biogen Piotroski F Score and Biogen Altman Z Score analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.